ASX - By Stock
|
ANO |
Re:
Ann: Annual Report to shareholders
|
|
Eski87
|
68 |
20K |
5 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
68
|
20K
|
5
|
|
ASX - By Stock
|
ANO |
Re:
Ann: Annual Report to shareholders
|
|
Eski87
|
68 |
20K |
3 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
68
|
20K
|
3
|
|
ASX - By Stock
|
ANO |
Re:
ANO **
|
|
Eski87
|
9 |
3.2K |
2 |
18/08/23 |
18/08/23 |
ASX - By Stock
|
9
|
3.2K
|
2
|
|
ASX - By Stock
|
CGS |
Re:
Biogen and Apple study early signs of Cognitive Impairment
|
|
Eski87
|
8 |
2.3K |
0 |
16/01/21 |
16/01/21 |
ASX - By Stock
|
8
|
2.3K
|
0
|
|
ASX - By Stock
|
CGS |
Re:
Biogen and Apple study early signs of Cognitive Impairment
|
|
Eski87
|
8 |
2.3K |
1 |
13/01/21 |
13/01/21 |
ASX - By Stock
|
8
|
2.3K
|
1
|
|
ASX - By Stock
|
ANO |
Re:
Ann: Strategy Update
|
|
Eski87
|
16 |
8.8K |
3 |
12/01/21 |
12/01/21 |
ASX - By Stock
|
16
|
8.8K
|
3
|
|
ASX - By Stock
|
CGS |
Re:
Putting numbers on it
|
|
Eski87
|
47 |
13K |
0 |
28/10/20 |
28/10/20 |
ASX - By Stock
|
47
|
13K
|
0
|
|
ASX - By Stock
|
ANO |
Re:
Ann: Chairman's Address to Shareholders
|
|
Eski87
|
39 |
17K |
0 |
22/10/20 |
22/10/20 |
ASX - By Stock
|
39
|
17K
|
0
|
|
ASX - By Stock
|
ANO |
Re:
Ann: Further Response to Shareholder's Questions
|
|
Eski87
|
3 |
2.1K |
4 |
20/10/20 |
20/10/20 |
ASX - By Stock
|
3
|
2.1K
|
4
|
|